Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Fenticonazole Nitrate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Monitor CRO | Exeltis
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of Efficacy and Safety of Two New Formulations Compared to Gynomax® XL Ovule
Details : Fenticonazole nitrate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Trichomonas Vaginitis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 28, 2023
Lead Product(s) : Fenticonazole Nitrate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Monitor CRO | Exeltis
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fenticonazole Nitrate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Monitor CRO
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioavailability Study of EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule
Details : Fenticonazole nitrate is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 04, 2022
Lead Product(s) : Fenticonazole Nitrate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Monitor CRO
Deal Size : Inapplicable
Deal Type : Inapplicable